Evidence map›Paper›PMID 28240243›Full record

ArticleScientific reports2017

SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.

Laurie M G de Kroon, Roberto Narcisi, Guus G H van den Akker, Elly L Vitters, Esmeralda N Blaney Davidson, Gerjo J V M van Osch, Peter M van der Kraan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Bone morphogenetic protein 4 is involved in cadmium-associated bone damage.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. SMAD4 contributes to chondrocyte and osteocyte development.Journal of cellular and molecular medicine · 2022
    Review
  13. Article
  14. Experimental biology and medicine (Maywood, N.J.) · 2020
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Laurie M G de KroonExperimental Rheumatology, Department of Rheumatology, Radboud University Medical Center, Nijmegen, 6500 HB, The Netherlands.
Roberto NarcisiDepartment of Orthopedics, Erasmus MC University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Guus G H van den AkkerExperimental Rheumatology, Department of Rheumatology, Radboud University Medical Center, Nijmegen, 6500 HB, The Netherlands.
Elly L VittersExperimental Rheumatology, Department of Rheumatology, Radboud University Medical Center, Nijmegen, 6500 HB, The Netherlands.
Esmeralda N Blaney DavidsonExperimental Rheumatology, Department of Rheumatology, Radboud University Medical Center, Nijmegen, 6500 HB, The Netherlands.
Gerjo J V M van OschDepartment of Orthopedics, Erasmus MC University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Peter M van der KraanExperimental Rheumatology, Department of Rheumatology, Radboud University Medical Center, Nijmegen, 6500 HB, The Netherlands.
Radboud University Nijmegen · NLErasmus MC · NLRadboud University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To improve cartilage formation by bone marrow-derived mesenchymal stem cells (BMSCs), the signaling mechanism governing chondrogenic differentiation requires better understanding. We previously showed that the transforming growth factor-β (TGFβ) receptor ALK5 is crucial for chondrogenesis induced by TGFβ. ALK5 phosphorylates SMAD2 and SMAD3 proteins, which then form complexes with SMAD4 to regulate gene transcription. By modulating the expression of SMAD2, SMAD3 and SMAD4 in human BMSCs, we investigated their role in TGFβ-induced chondrogenesis. Activation of TGFβ signaling, represented by SMAD2 phosphorylation, was decreased by SMAD2 knockdown and highly increased by SMAD2 overexpression. Moreover, TGFβ signaling via the alternative SMAD1/5/9 pathway was strongly decreased by SMAD4 knockdown. TGFβ-induced chondrogenesis of human BMSCs was strongly inhibited by SMAD4 knockdown and only mildly inhibited by SMAD2 knockdown. Remarkably, both knockdown and overexpression of SMAD3 blocked chondrogenic differentiation. Chondrogenesis appears to rely on a delicate balance in the amount of SMAD3 and SMAD4 as it was not enhanced by SMAD4 overexpression and was inhibited by SMAD3 overexpression. Furthermore, this study reveals that TGFβ-activated phosphorylation of SMAD2 and SMAD1/5/9 depends on the abundance of SMAD4. Overall, our findings suggest a more dominant role for SMAD3 and SMAD4 than SMAD2 in TGFβ-induced chondrogenesis of human BMSCs.

Indexed as

Cell DifferentiationChondrogenesisCells, CulturedGene ExpressionGene Knockdown TechniquesHumansMesenchymal Stem CellsPhosphorylationProtein Processing, Post-TranslationalSignal TransductionSmad2 ProteinSmad3 ProteinSmad4 ProteinTransforming Growth Factor betaSmad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanSmad4 ProteinSMAD4 protein, humanTransforming Growth Factor beta

Identifiers

PMID28240243
PMCPMC5327413
OpenAlexW2594683771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.